Research News From September 23, 2015
advertisement
- Home Use of an Artificial Beta Cell in Type 1 Diabetes. Free full text available in PDF format.
- Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System’s Fuzzy Logic Controller.
- Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas.
- Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes.
- EASD: Intranasal glucagon reverses hypoglycemia in children and adolescents.
- Efficacy and safety of canagliflozin: results of an 18-week phase 2 study in patients with type 1 diabetes. See also Invokana lowers HbA1c and aids weight loss in adults with type 1 diabetes, study finds and First Data on SGLT2 Inhibitor Canagliflozin in Type 1 Diabetes.
- Update on ketoacidosis with SGLT2 inhibitors.